PL1799231T3 - Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli - Google Patents

Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli

Info

Publication number
PL1799231T3
PL1799231T3 PL05801277T PL05801277T PL1799231T3 PL 1799231 T3 PL1799231 T3 PL 1799231T3 PL 05801277 T PL05801277 T PL 05801277T PL 05801277 T PL05801277 T PL 05801277T PL 1799231 T3 PL1799231 T3 PL 1799231T3
Authority
PL
Poland
Prior art keywords
prevention
treatment
inflammatory diseases
cyclodextrin
bronchial inflammatory
Prior art date
Application number
PL05801277T
Other languages
English (en)
Inventor
Didier Cataldo
Brigitte Evrard
Agnes Noel
Jean-Michel Foidart
Original Assignee
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liege filed Critical Univ Liege
Publication of PL1799231T3 publication Critical patent/PL1799231T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL05801277T 2004-10-10 2005-09-30 Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli PL1799231T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04104957A EP1655034A1 (en) 2004-10-10 2004-10-10 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases.
EP05801277A EP1799231B1 (en) 2004-10-10 2005-09-30 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases
PCT/EP2005/054966 WO2006037769A1 (en) 2004-10-10 2005-09-30 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases.

Publications (1)

Publication Number Publication Date
PL1799231T3 true PL1799231T3 (pl) 2010-07-30

Family

ID=34929683

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05801277T PL1799231T3 (pl) 2004-10-10 2005-09-30 Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli

Country Status (8)

Country Link
US (3) US7829550B2 (pl)
EP (2) EP1655034A1 (pl)
JP (1) JP4989481B2 (pl)
AT (1) ATE456955T1 (pl)
DE (1) DE602005019247D1 (pl)
ES (1) ES2340511T3 (pl)
PL (1) PL1799231T3 (pl)
WO (1) WO2006037769A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9545424B2 (en) 2007-06-01 2017-01-17 SolAero Med Inc. Method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof
US9617197B2 (en) * 2010-08-04 2017-04-11 University Of Virginia Patent Foundation Compositions and methods for treating inflammatory diseases
CA2880880C (en) 2012-08-03 2021-01-26 John Mckew Cyclodextrin for the treatment of lysosomal storage diseases
RU2506080C1 (ru) * 2012-09-25 2014-02-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО НижГМА Минздравсоцразвития России) Способ лечения и профилактики осложнений в полости рта, вызванных приемом ингаляционных гормональных препаратов у больных бронхиальной астмой
WO2014047715A1 (en) * 2012-09-27 2014-04-03 Solaeromed Inc. Treatment of pulmonary surfactant dysfunction using cholesterol-sequestering cyclodextrins
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl
NZ724902A (en) * 2014-03-28 2023-03-31 Univ Liege Composition comprising cyclodextrin and budesonide derivatives for the treatment and prophylaxis of pulmonary inflammations
EP2923702A1 (en) * 2014-03-28 2015-09-30 Universite De Liege Composition of cyclodextrin with budesonide derivatives for treatment and prevention of pulmonary inflammatory disease
EP3307278A4 (en) 2015-06-10 2018-06-13 Vtesse, Inc. Hydroxypropyl beta-cyclodextrin compositions and methods
US20210253746A1 (en) * 2018-06-29 2021-08-19 Roquette Freres Novel hydroxypropyl-beta-cyclodextrin and process for the production thereof
FR3083234B1 (fr) * 2018-06-29 2020-11-27 Roquette Freres Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation
BE1027425B1 (fr) 2019-07-01 2021-02-08 Aquilon Pharmaceuticals Composition inhalable comprenant de la cyclodextrine a utiliser dans le traitement d’inflammations nasales
BE1027612B1 (fr) 2019-09-10 2021-05-03 Aquilon Pharmaceuticals Microparticules en forme de balle de golf pour une utilisation dans le traitement et la prevention de maladies pulmonaires
US11045434B1 (en) 2020-04-01 2021-06-29 UNION therapeutics A/S Niclosamide formulations for treating disease
MA53516A1 (fr) * 2020-06-15 2022-04-29 Univ Liege Cyclodextrine utilisée dans le traitement et la prévention de la bronchoconstriction en phase tardive de l'asthme provoqué par des allergènes.
WO2023118014A1 (en) 2021-12-20 2023-06-29 Aquilon Pharmaceuticals Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease
BE1030002B1 (fr) 2021-12-29 2023-09-01 Aquilon Pharmaceuticals Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire
WO2023156966A1 (en) 2022-02-18 2023-08-24 Beren Therapeutics P.B.C. Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054736A (en) * 1970-06-10 1977-10-18 Ono Pharmaceutical Co., Ltd. Clathrate compounds of prostaglandins or their analogues with cyclodextrin
JPS62123132A (ja) * 1985-11-21 1987-06-04 Michio Nakanishi 気管支喘息治療用組成物
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
US5840713A (en) * 1995-04-03 1998-11-24 Weisz; Paul B. Therapy for tissue membrane insufficiency
EP0934341A1 (en) * 1996-10-28 1999-08-11 Farmac Nederland B.V. Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品

Also Published As

Publication number Publication date
US7829550B2 (en) 2010-11-09
WO2006037769A1 (en) 2006-04-13
EP1799231B1 (en) 2010-02-03
ATE456955T1 (de) 2010-02-15
ES2340511T3 (es) 2010-06-04
JP4989481B2 (ja) 2012-08-01
US20090012041A1 (en) 2009-01-08
JP2008515847A (ja) 2008-05-15
EP1655034A1 (en) 2006-05-10
US20120295872A1 (en) 2012-11-22
EP1799231A1 (en) 2007-06-27
DE602005019247D1 (de) 2010-03-25
US20110028432A1 (en) 2011-02-03

Similar Documents

Publication Publication Date Title
PL1799231T3 (pl) Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
WO2006119295A3 (en) Compositions and methods for the treatment of neurodegenerative diseases
ZA200801171B (en) 3, IIB-CIS-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
WO2006120176A3 (en) Combination of the pde4 inhibitor roflumilast and a tetrahydrobiopterin derivative
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
WO2005085266A3 (en) Macrocyclic compounds and methods of making and using the same
IL184124A0 (en) Medicaments for the treatment or prevention of fibrotic diseases
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
ZA200800981B (en) Use of SDF-1 for the treatment and/or prevention of neurological diseases
UA88655C2 (ru) S-миртазапин для лечения прилива крови
WO2007054566A3 (en) Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
IL182008A (en) Use of an antithrombotic compound for the manufacture of a medicament for pulmonary delivery for prevention or treatment of thrombosis or related disorders
WO2008112701A3 (en) G-substrate for the treatment and prevention of parkinson's disease
IL190842A0 (en) Use of sdf-1 for the treatment and/or prevention of neurological diseases
AU2004903986A0 (en) Compounds for the Treatment of Vascular Diseases
AU2005900589A0 (en) Soy-derived products for the treatment of vascular diseases